Past mini-conference participant Boris Hauray and colleagues are publishing a new edited volume, Conflict of Interest and Medicine: Knowledge, Practices, and Mobilizations, coming out in September 2021.
The volume includes a chapter from Hauray on “A Genealogy of Conflict of Interest”, and another chapter from mini-conference organizer Étienne Nouguez on “In Whose Best Interest? Framing Pharmacists’ and Physicians’ (Conflicts of) Interest in the French Market for Generic Drugs”.
Other contributors to the volume include Melanie Jeske, Annie Martin, Jérôme Greffion, Hélène Michel, Marc Rodwin, Henri Boullier, Jean-Paul Gaudillière, Solène Lellinger, Christian Bonah, Giovanni Prete, Jean-Noël Jouzel, François Dedieu, Emmanuel Henry, and Sergio Sismondo.
A blurb from the publisher can be seen below:
In the context of a growing criticism on the influence of the pharmaceutical industry on physicians, scientists, or politicians, Conflict of Interest and Medicine offers a comprehensive analysis of the conflict of interest in medicine anchored in the social sciences, with perspectives from sociology, history, political science, and law.
Based on in-depth empirical investigations conducted within different territories (France, the European Union, and the United States) the contributions analyze the development of conflict of interest as a social issue and how it impacts the production of medical knowledge and expertise, physicians’ work and their prescriptions, and also the framing of health crises and controversies. In doing so, they bring a new understanding of the transformations in the political economy of pharmaceutical knowledge, the politicization of public health risks, and the promotion of transparency in science and public life.
Complementing the more normative and quantitative understandings of conflict of interest issues that dominate today, this book will be of interest to researchers in a broad range of areas including social studies of sciences and technology, sociology of health and illness, and political sociology and ethics. It will be also a valuable resource for health professionals, medical scientists, or regulators facing the question of corporate influence.
Learn more about and order the book here.